Literature DB >> 15389291

Heme-oxygenase-mediated iron accumulation in the liver.

Zia A Khan1, Yousef P Barbin, Mark Cukiernik, Paul C Adams, Subrata Chakrabarti.   

Abstract

Heme oxygenase (HO) isozymes, HO-1 and HO-2, catalyze the conversion of heme to iron, carbon monoxide, and biliverdin. The present study was aimed at elucidating the role of the HO system in iron accumulation and oxidative stress in the liver. We have also studied the regulation of an iron exporter, ferroportin-1 (FPN-1), as an adaptive response mechanism to increased iron levels. Sprague-Dawley rats were treated with HO inducer hemin or HO inhibitor tin-protoporphyrin IX (SnPPIX) for 1 month. A portion of liver tissues was subjected to RT-PCR for HO-1, HO-2, and FPN-1 gene expression as well as an HO activity assay. Paraffin-embedded tissues were stained for iron with Prussian blue. Hepatic iron concentration was measured by High Resolution-Inductively Coupled Plasma-Mass Spectrometry. 8-hydroxy-2'-deoxyguanosine (8-OHdG) stain, a sensitive and specific marker of oxidative DNA damage, was performed to assess oxidative stress. Hemin treatment led to augmented HO expression and activity in association with increased iron accumulation and oxidative stress. FPN-1 expression was also found to be upregulated. SnPPIX treatment reduced HO activity, intracellular iron levels, and oxidative stress as compared to controls. Our data provides evidence of increased HO activity as an important pro-oxidant mechanism leading to iron accumulation in the liver.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15389291     DOI: 10.1139/y04-052

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  9 in total

1.  Beta-Carotene Affects the Effects of Heme Oxygenase-1 in Isolated, Ischemic/Reperfused Rat Hearts: Potential Role of the Iron.

Authors:  Evelin Csepanyi; Alexandra Gyongyosi; Istvan Lekli; Arpad Tosaki; Istvan Bak
Journal:  Molecules       Date:  2022-05-09       Impact factor: 4.927

2.  Up-regulation of heme oxygenase-1 in rat spleen after aniline exposure.

Authors:  Jianling Wang; Huaxian Ma; Paul J Boor; V M Sadagopa Ramanujam; G A S Ansari; M Firoze Khan
Journal:  Free Radic Biol Med       Date:  2009-12-04       Impact factor: 7.376

3.  Krill oil alleviates oxidative stress, iron accumulation and fibrosis in the liver and spleen of iron-overload rats.

Authors:  Manar G Helal; Dalia H El-Kashef
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-10       Impact factor: 4.223

4.  Differential effects of curcumin on vasoactive factors in the diabetic rat heart.

Authors:  Hana Farhangkhoee; Zia A Khan; Shali Chen; Subrata Chakrabarti
Journal:  Nutr Metab (Lond)       Date:  2006-07-18       Impact factor: 4.169

5.  Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats.

Authors:  Ahmed Atwa; Rehab Hegazy; Rania Mohsen; Neamat Yassin; Sanaa Kenawy
Journal:  Open Access Maced J Med Sci       Date:  2017-12-13

6.  SIRT3 Deficiency Sensitizes Angiotensin-II-Induced Renal Fibrosis.

Authors:  Xiaomeng Feng; Han Su; Xiaochen He; Jian-Xiong Chen; Heng Zeng
Journal:  Cells       Date:  2020-11-20       Impact factor: 6.600

7.  Sex-dependent effects of long-term clozapine or haloperidol medication on red blood cells and liver iron metabolism in Sprague Dawley rats as a model of metabolic syndrome.

Authors:  Marie-Luise Bouvier; Karin Fehsel; Andrea Schmitt; Eva Meisenzahl-Lechner; Wolfgang Gaebel; Martina von Wilmsdorff
Journal:  BMC Pharmacol Toxicol       Date:  2022-01-15       Impact factor: 2.483

8.  Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation.

Authors:  Qiu-Ming Wang; Jian-Ling Du; Zhi-Jun Duan; Shi-Bin Guo; Xiao-Yu Sun; Zhen Liu
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.374

9.  Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice.

Authors:  Xiaomeng Feng; Shuo Wang; Zhencheng Sun; Hengbei Dong; Haitian Yu; Mengxiu Huang; Xia Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-18       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.